Man Group’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-42,415
| Closed | -$399K | – | 2017 |
|
|
2023
Q4 | $399K | Buy |
+42,415
| New | +$399K | ﹤0.01% | 1621 |
|
|
2023
Q1 | – | Sell |
-13,698
| Closed | -$637K | – | 2066 |
|
|
2022
Q4 | $637K | Buy |
+13,698
| New | +$637K | ﹤0.01% | 1442 |
|
|
2021
Q1 | – | Sell |
-177,288
| Closed | -$7.46M | – | 1885 |
|
|
2020
Q4 | $7.46M | Sell |
177,288
-56,532
| -24% | -$2.38M | 0.03% | 576 |
|
|
2020
Q3 | $10.7M | Buy |
233,820
+63,496
| +37% | +$2.91M | 0.04% | 445 |
|
|
2020
Q2 | $8.55M | Sell |
170,324
-26,281
| -13% | -$1.32M | 0.04% | 417 |
|
|
2020
Q1 | $10.1M | Sell |
196,605
-103,480
| -34% | -$5.32M | 0.07% | 288 |
|
|
2019
Q4 | $18.5M | Buy |
300,085
+4,131
| +1% | +$255K | 0.06% | 381 |
|
|
2019
Q3 | $17.8M | Buy |
295,954
+190,743
| +181% | +$11.5M | 0.07% | 346 |
|
|
2019
Q2 | $8.88M | Buy |
105,211
+34,100
| +48% | +$2.88M | 0.03% | 676 |
|
|
2019
Q1 | $6.79M | Buy |
71,111
+39,023
| +122% | +$3.73M | 0.03% | 748 |
|
|
2018
Q4 | $2.27M | Sell |
32,088
-36,329
| -53% | -$2.57M | 0.01% | 1151 |
|
|
2018
Q3 | $5.85M | Sell |
68,417
-59,900
| -47% | -$5.12M | 0.02% | 890 |
|
|
2018
Q2 | $14.9M | Sell |
128,317
-147,425
| -53% | -$17.1M | 0.06% | 381 |
|
|
2018
Q1 | $22.3M | Buy |
+275,742
| New | +$22.3M | 0.1% | 200 |
|